Related Experiment Videos
Cytokines in multiple sclerosis: from bench to bedside.
Jaime Imitola1, Tanuja Chitnis, Samia J Khoury
1Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Rm 710, Boston, MA 02115, USA.
Pharmacology & Therapeutics
|May 4, 2005
Summary
Cytokines are key players in multiple sclerosis (MS) pathogenesis. Understanding their complex roles, particularly through experimental autoimmune encephalomyelitis (EAE) models, is crucial for developing effective MS treatments targeting these inflammatory pathways.
Area of Science:
- Neuroimmunology
- Inflammatory Diseases
- Molecular Biology
Background:
- Cytokines are critical in the development of inflammatory diseases like multiple sclerosis (MS).
- Experimental models are vital for studying cytokine roles, though results can be complex and sometimes conflicting.
- Modulating cytokine function has proven effective in MS treatment, targeting central nervous system (CNS) and mononuclear cell expression.
Purpose of the Study:
- To review the current understanding of cytokine pathways in multiple sclerosis (MS).
- To discuss insights gained from the experimental autoimmune encephalomyelitis (EAE) model in relation to MS.
- To highlight cytokines as significant therapeutic targets for MS.
Main Methods:
- Literature review of studies on cytokine roles in MS.
- Analysis of findings from experimental autoimmune encephalomyelitis (EAE) models.
- Examination of therapeutic strategies targeting cytokine modulation in MS.
Main Results:
- Cytokine pathways are integral to MS pathogenesis.
- The EAE model provides valuable, albeit complex, information on cytokine involvement.
- Altered cytokine expression in the CNS and peripheral immune cells correlates with MS disease activity and treatment response.
Conclusions:
- Cytokines are essential therapeutic targets for managing multiple sclerosis (MS).
- Continued research, including studies on animal models like EAE, is necessary to fully elucidate complex cytokine networks in MS.
- Understanding cytokine dynamics is key to advancing MS treatment strategies.